Research Training in Natural Product Complementary and Integrative Health

天然产品补充和综合健康研究培训

• 批准号: 10063973
• 负责人: TAIFO MAHMUD
• 金额: $ 24.38万
• 依托单位: OREGON STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-12-01 至 2024-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10063973
• 关键词: Complementary Health; Integrative Medicine; Natural Products; Research Training

PROJECT SUMMARY/ABSTRACT Founded 120 years ago, the Oregon State University (OSU) College of Pharmacy is one of the oldest in the United States and has been a leader in natural products research since our predoctoral training program in Pharmaceutical Sciences began in 1952. Founded in 1973 by two-time Nobel Laureate Linus Pauling and housed in the state-of-the-art Linus Pauling Science Center on the OSU campus, the Linus Pauling Institute (LPI) remains focused on using micronutrients, phytochemicals and dietary supplements to prevent disease and maintain human health. Our graduates occupy leadership positions in academia, industry and government in the United States and throughout the world. Historically, natural products have accounted for over half of all therapeutic agents, and today are still the inspiration of nearly 40% of new drugs. Training young scientists for careers in natural products and dietary supplements research is a core mission of our College of Pharmacy and the LPI and will be the focus of this training grant. To address the need to train a new generation of experts in research concerning natural products drug discovery and in the safety and efficacy of dietary supplements, we propose to establish a new training grant program that will enroll 5 predoctoral trainees at a time. Currently, there is no training grant based in the OSU College of Pharmacy or the LPI. Our mentor team includes faculty with expertise in marine, microbial and botanical natural products and dietary supplements as well as natural product genomics, cancer therapy, chemoprevention, pharmacology, dietary supplements, organic synthesis, and biosynthesis. Our leadership team includes co-Program Leaders with experience leading a T32 training program (Dr. van Breemen) and experience serving as a director of graduate studies for our department (Dr. Mahmud). Finally, our training program will be enhanced by exceptional institutional commitment in the forms of administrative support from the OSU College of Pharmacy, the Department of Pharmaceutical Sciences and the LPI and financial support from the OSU Graduate School as partial tuition waivers.

项目总结/文摘